Annovis Bio, Inc. (ANVS) Deep Dive Video

Summary

An oral, multi-protein Alzheimer’s/Parkinson’s bet with a 2047 patent runway—priced like failure, valued like a breakthrough if Phase 3 hits.

View ANVS stock page · Read the ANVS research report

Loading the video player…